Federal law doesn't protect BRCA carriers in life insurance. Your state might. Here's the complete, honest picture — before you test, after you test, and after a diagnosis.
📅 Updated November 2026⏱️ 12 min read🧬 GINA gap explained
🧬
Reviewed by the DNAPolicy.org Editorial Team
Our genetics and life insurance guides are reviewed for accuracy by licensed insurance professionals and cross-referenced with current underwriting guidelines. Content is updated regularly to reflect industry changes. Last reviewed: November 2026
The Most Important Thing to Know
Federal law (GINA) does not protect BRCA carriers in life insurance. GINA covers health insurance and employment only. This is called the "GINA gap" — and it's the reason timing, state of residence, and strategy matter so much for BRCA carriers shopping for life insurance.
In most U.S. states, a life insurer can legally ask if you've had genetic testing and use your BRCA status in underwriting decisions. Some states protect you. Many don't.
BRCA + Life Insurance Strategy Tool
Your situation determines your strategy.
Your situation + strategy
BRCA carrier, no cancer diagnosis, in a protective state. Life insurer likely cannot use your BRCA status in underwriting. Standard rates based on overall health are likely available. Work with an independent broker and disclose accurately.
BRCA1 vs. BRCA2 — What Each Means
BRCA1
Lifetime cancer risks:
55–72% lifetime breast cancer risk
44% ovarian cancer risk
Triple-negative breast cancer association (harder to treat)
Earlier onset cancers typical
Inheritance: Autosomal dominant — 50% chance of passing to each child
Prevalence: ~1 in 400 people; higher in Ashkenazi Jewish population (~1 in 40)
BRCA2
Lifetime cancer risks:
45–69% lifetime breast cancer risk
17% ovarian cancer risk
Elevated male breast cancer risk (~7%)
Elevated pancreatic + prostate cancer risk
Somewhat less aggressive biology than BRCA1
Inheritance: Autosomal dominant — 50% chance of passing to each child
Prevalence: ~1 in 400 people; higher in Ashkenazi Jewish population (~1 in 40)
Genetic counselors routinely discuss insurance implications with patients before BRCA testing. One common recommendation: if you have strong family history suggesting BRCA, consider securing life insurance before the test results enter your medical record.
Once a life insurance policy is in force for 2 years (the incontestability period), the insurer cannot cancel or contest the policy based on information discovered afterward — including genetic test results obtained after issuance.
1
Consult a genetic counselor
Before deciding whether to test, understand the full implications — medical, psychological, and insurance.
2
Secure life insurance
Apply for the coverage you need. Answer all questions accurately based on current information — do not misrepresent.
3
Wait 2 years
After 2 years, the incontestability period ends. The policy is iron-clad regardless of subsequent discoveries.
4
Proceed with testing
Now test with the peace of mind that your coverage is protected regardless of results.
⚠️ Important: Never misrepresent or omit material information on a life insurance application. This strategy only works if you are fully forthcoming about everything you currently know.
Risk-Reducing Surgery and Insurance
Prophylactic bilateral mastectomy
Risk reduction: ~90–95% reduction in breast cancer risk
Major positive underwriting signal. Demonstrates proactive risk management. Underwriters specifically note this as a favorable factor for BRCA carriers.
Source: Domchek et al., JAMA 2010
Bilateral salpingo-oophorectomy (BSO)
Risk reduction: ~80% reduction in ovarian cancer risk + ~50% further reduction in breast cancer risk (if premenopausal)
Major positive underwriting signal. Eliminates ovarian cancer risk factor and further reduces breast cancer risk. Strongest favorable signal available for BRCA carriers.
Source: NCCN Guidelines; Rebbeck et al., NEJM 2002
If I have a BRCA mutation, can a life insurer deny me coverage?
Yes — in most U.S. states. This is one of the most important distinctions in genetic law. Federal GINA (Genetic Information Nondiscrimination Act) protects you in health insurance and employment, but explicitly does NOT cover life insurance, disability insurance, or long-term care insurance. This means life insurers in most states can legally ask about genetic test results and use a BRCA mutation in underwriting decisions. However: (1) many major carriers currently do not use direct-to-consumer (DTC) genetic test results (23andMe, Ancestry) in practice, (2) a BRCA mutation without a cancer diagnosis is treated very differently from a cancer diagnosis, and (3) Florida, California, New York, and several other states have enacted state-level protections. Know your state before testing.
What is the difference between BRCA1 and BRCA2 for life insurance?
Both BRCA1 and BRCA2 are tumor suppressor genes. When mutated, they lose the ability to repair DNA damage, leading to elevated cancer risk. BRCA1 mutations: approximately 55-72% lifetime breast cancer risk, 44% ovarian cancer risk (National Cancer Institute data). Associated with higher-grade, triple-negative breast cancers. BRCA2 mutations: approximately 45-69% lifetime breast cancer risk, 17% ovarian cancer risk. Associated with slightly less aggressive breast cancer biology. Also elevated risk of male breast cancer, pancreatic cancer, and prostate cancer. For life insurance underwriting: if you carry either mutation without a cancer diagnosis, underwriting depends heavily on state law and carrier policy. With a cancer diagnosis, the cancer history drives underwriting — same as any other cancer survivor.
What if I have a BRCA mutation but have never been diagnosed with cancer?
This is the critical scenario that most articles miss. Without a cancer diagnosis: (1) In states with genetic privacy protections (CA, FL, NY, MA, NJ, MD, CO, CT, DE, AZ, WA and others), life insurers cannot use your BRCA test results in underwriting. (2) In other states, insurers can legally ask — but most major carriers currently don't use DTC test results in practice. Clinical genetic test results in your medical chart are more accessible via HIPAA-authorized medical records review. (3) Strategy: if you know you carry a BRCA mutation and don't yet have cancer, consider securing life insurance before genetic test results enter your medical record — or choose a carrier in a protective state. (4) Risk-reducing surgeries (prophylactic mastectomy, oophorectomy) are viewed positively by underwriters — they demonstrate proactive risk management.
What if I had breast cancer because of a BRCA mutation?
With a BRCA-related cancer diagnosis, you are underwritten on the cancer history (same as any other survivor) with the BRCA mutation noted as an additional ongoing risk factor. See our Life Insurance After Cancer guide for the full framework. The key factors: cancer type and stage at diagnosis, time since treatment, current remission status, and whether risk-reducing surgeries have been performed. The BRCA mutation adds an ongoing cancer risk signal that underwriters note, but it doesn't automatically result in a decline — especially if significant time has passed and risk-reducing measures have been taken.
What is a risk-reducing surgery and how does it affect my life insurance?
Risk-reducing surgeries for BRCA carriers include: prophylactic bilateral mastectomy (reduces breast cancer risk by approximately 90-95%) and bilateral salpingo-oophorectomy (removes ovaries and fallopian tubes, reduces ovarian cancer risk by approximately 80% and further reduces breast cancer risk). Life insurance underwriters view these surgeries as highly positive indicators — they demonstrate that the BRCA carrier is proactively managing their risk. BRCA carriers who have undergone risk-reducing surgeries are underwritten significantly more favorably than those who have not, particularly for traditional coverage. Document these surgeries clearly in your medical records before applying.
Should I get life insurance before getting a BRCA test?
This is a strategy worth seriously considering, particularly if you have a strong family history of BRCA-related cancers. If you secure a life insurance policy before testing, the insurer cannot use your genetic test results to rescind coverage (policies generally cannot be cancelled based on information discovered after issuance — this is the incontestability principle after 2 years). After the policy is in force for 2 years, it is essentially iron-clad. This timing strategy is legal, ethical, and commonly recommended by genetic counselors when discussing insurance implications with pre-test patients. Important: once you apply with any insurer, they may access your records and find prior documentation of BRCA family history. This is different from your own test result, but worth understanding.
What states have BRCA / genetic protection laws for life insurance?
State-level genetic privacy laws for life insurance vary significantly. States with the strongest protections (prohibit or restrict use of genetic information in life insurance underwriting): California, Florida, New York, New Jersey, Massachusetts, Maryland, Colorado, Connecticut, Delaware, Arizona, and Washington. States with partial protections or pending legislation: varies — check with your state insurance commissioner. Most states: federal GINA does not apply to life insurance, and state law may not provide protection. If you live in a state without protection and carry a BRCA mutation, your options include: applying with carriers who voluntarily don't use DTC results, applying before testing, or applying in a state with protections (legal if you establish residence). See our complete GINA state-by-state guide for the full current picture.
What is the BRCA Exchange and does sharing my data affect my insurance?
The BRCA Exchange (brcaexchange.org) is a research database that aggregates BRCA variant classifications from laboratories worldwide to improve interpretation of genetic variants of uncertain significance (VUS). Sharing your BRCA data with the BRCA Exchange or similar research databases is voluntary and does not give life insurers access to your information. Life insurers access genetic information through your medical records (via HIPAA authorization you sign during the application) and through direct questions on the application. Research databases are not part of this pathway.
Timing and strategy make all the difference.
Know your state's protections. Understand the insurance-before-testing strategy. If you've already tested, understand your options clearly.